Ahmed Souka, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4825 Nw Fielding Rd Apt 5, Topeka, KS 66618 Phone: 516-853-6447 |
Amit Kumar, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6730 Sw 29th St Ste B, Topeka, KS 66614 Phone: 785-262-9911 Fax: 785-816-0020 |
Dr. Jack A Jones, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 |
Dr. Francis J Weyrens, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 Fax: 785-270-4196 |
Dr. Brian M Beard, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 Fax: 785-270-4196 |
News Archive
Scientists have developed a brain implant that essentially melts into place, snugly fitting to the brain's surface. The technology could pave the way for better devices to monitor and control seizures, and to transmit signals from the brain past damaged parts of the spinal cord.
Novartis and the Broad Institute have developed a cancer cell line encyclopedia that catalogues the genetic and molecular profiles of almost 1,000 human cancer cell lines used in drug research and development. Results of the collaboration, published in the journal Nature and released in advance online today, may allow scientists around the world to use this information to improve cancer clinical trial design and further cancer research.
When a cell divides, its constituents are usually evenly distributed among the daughter cells. UZH researchers have now identified an enzyme that guarantees that cell constituents that are concentrated in organelles without a membrane are properly distributed.
Transfusion of donated blood more than three weeks old results in impaired blood vessel function, a new study of hospital patients shows.
Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological Association (AUA) Annual Scientific Meeting in Chicago.
› Verified 3 days ago